Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection | Zendy

Mehmet Sezgin Pepeler | Zendy; Şeyma Yıldız | Zendy; Zeynep Arzu Yeğin | Zendy; Zübeyde Nur Özkurt | Zendy; Özlem Güzel Tunçcan | Zendy; Gonca Erbaş | Zendy; Nurdan Köktürk | Zendy; Ayşe Kalkancı | Zendy; Zeki Yıldırım | Zendy

Open Access

Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection

Author(s) -

Mehmet Sezgin Pepeler,

Şeyma Yıldız,

Zeynep Arzu Yeğin,

Zübeyde Nur Özkurt,

Özlem Güzel Tunçcan,

Gonca Erbaş,

Nurdan Köktürk,

Ayşe Kalkancı,

Zeki Yıldırım

Publication year - 2018

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.9961

Subject(s) - antifungal , hematopoietic stem cell , hematopoietic stem cell transplantation , secondary prophylaxis , medicine , haematopoiesis , stem cell , hematopoietic cell , immunology , transplantation , biology , microbiology and biotechnology , genetics

Invasive fungal infection (IFI) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. A previous history of IFI is not an absolute contraindication for allo-HSCT, particularly in the era of secondary antifungal prophylaxis (SAP). Prompt diagnosis and therapy are essential for HSCT outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research